Literature DB >> 8389381

Clinical neurophysiology of disorders of the neuromuscular junction.

D B Sanders1.   

Abstract

This is a review of the neurophysiological techniques used clinically to demonstrate abnormalities of neuromuscular transmission. The use of these tests in myasthenia gravis, Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, and other conditions with disturbed neuromuscular transmission is presented.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8389381     DOI： 10.1097/00004691-199304000-00004

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN： 0736-0258            Impact factor:   2.177


  9 in total

1.  A case of Addison's disease associated with the Lambert-Eaton myasthenic syndrome.

Authors:  M Ozata; Z Odabasi; U Musabak; A Corakci; M A Gundogan
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

2.  Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.

Authors:  Natalie Tsinzerling; Ann-Kari Lefvert; Georg Matell; Ritva Pirskanen-Matell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

3.  CMAP decrement by low-frequency repetitive nerve stimulation in different hand muscles of ALS patients.

Authors:  Dong Zhang; Yuying Zhao; Chuanzhu Yan; Lili Cao; Wei Li
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

4.  Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome.

Authors:  P Maddison; J Newsom-Davis; K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

5.  Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.

Authors:  Yonghao Cao; Robert A Amezquita; Steven H Kleinstein; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

6.  Clinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors.

Authors:  Hyo Eun Lee; Yool Hee Kim; Seung Min Kim; Ha Young Shin
Journal:  J Clin Neurol       Date:  2016-10       Impact factor: 3.077

7.  Correlations between slow-rate repetitive nerve stimulation and characteristics associated with amyotrophic lateral sclerosis in Chinese patients.

Authors:  Yan Wang; Zheman Xiao; Hong Chu; Jingjing Liang; Xu Wu; Hongjuan Dong; Yang Yan; Zuneng Lu
Journal:  J Phys Ther Sci       Date:  2017-04-20

Review 8.  Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis.

Authors:  Karissa L Gable; Jeffrey T Guptill
Journal:  Front Immunol       Date:  2020-01-10       Impact factor: 7.561

9.  Repetitive Nerve Stimulation in Amyotrophic Lateral Sclerosis.

Authors:  Xiao-Sun Sun; Wen-Xiu Liu; Zhao-Hui Chen; Li Ling; Fei Yang; Hong-Fen Wang; Fang Cui; Xu-Sheng Huang
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.